Literature DB >> 19546344

Tobacco, public health, and the FDA.

Gregory D Curfman, Stephen Morrissey, Jeffrey M Drazen.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19546344     DOI： 10.1056/NEJMe0905622

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

1.  Biomarkers increase detection of active smoking and secondhand smoke exposure in critically ill patients.

Authors:  S Jean Hsieh; Lorraine B Ware; Mark D Eisner; Lisa Yu; Peyton Jacob; Christopher Havel; Maciej L Goniewicz; Michael A Matthay; Neal L Benowitz; Carolyn S Calfee
Journal:  Crit Care Med       Date:  2011-01       Impact factor: 7.598

Review 2.  Review of epidemiologic data on the debate over smokeless tobacco's role in harm reduction.

Authors:  David S Timberlake; Jason A Zell
Journal:  BMC Med       Date:  2009-10-19       Impact factor: 8.775

3.  Health effects of the Federal Bureau of Prisons tobacco ban.

Authors:  Stephen A Martin; Bartolome R Celli; Joseph R DiFranza; Stephen J Krinzman; Jennifer G Clarke; Herbert Beam; Sandra Howard; Melissa Foster; Robert J Goldberg
Journal:  BMC Pulm Med       Date:  2012-10-15       Impact factor: 3.317
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.